发明名称 |
METHOD FOR THE IMPROVEMENT OF ISLET SIGNALING IN DIABETES MELLITUS AND FOR ITS PREVENTION |
摘要 |
The present invention discloses a method for therapeutically treating mammal s, including but not limited to humans, to increase the relative insulin producing performance of endogenous pancreatic .beta.-cells and to cause differentiation of pancreatic epithelial cells into insulin producing .beta. - cells. Oral administration of a DP IV inhibitor causes the active form of GL P- 1 to be preserved longer under physiological conditions. The extended presen ce of GLP-1, in particular in the pancreatic tissue facilitates differentiation and regeneration of the .beta.-cells already present that are in need of repair. These repaired insulin producing cells can contribute to the correction and maintenance of normal physiological glycemic levels.
|
申请公布号 |
CA2400226(A1) |
申请公布日期 |
2001.10.04 |
申请号 |
CA20012400226 |
申请日期 |
2001.04.02 |
申请人 |
PROBIODRUG AG |
发明人 |
GLUND, KONRAD;DEMUTH, HANS-ULRICH |
分类号 |
C07D277/04;A61K31/00;A61K31/40;A61K31/401;A61K31/425;A61K31/426;A61K38/00;A61K45/00;A61K45/06;A61P3/10;A61P5/50;A61P19/02;A61P29/00;A61P31/18;A61P37/06;A61P43/00;(IPC1-7):A61K31/425 |
主分类号 |
C07D277/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|